Showing 961 - 980 results of 2,510 for search '"Clinical research"', query time: 0.11s Refine Results
  1. 961
  2. 962
  3. 963

    A Novel COL7A1 Mutation in a Patient With Dystrophic Epidermolysis Bullosa. Successful Treatment With Upadacitinib by Lai S, Lin C, Guo Z, Lai Y, Xie L, Wan C, Yang T, Li L

    Published 2025-01-01
    “…Shuqin Lai,* Chunli Lin,* Zimeng Guo, Yun Lai, Ling Xie, Chunlei Wan, Tao Yang, Longnian Li Department of Dermatology, Candidate Branch of National Clinical Research Centre for Skin and Immune Diseases, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Tao Yang; Longnian Li, Department of Dermatology, Candidate Branch of National Clinical Research Centre for Skin and Immune Diseases, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, People’s Republic of China, Email danny20021068@126.com; li_longnian@foxmail.comAbstract: Dystrophic epidermolysis bullosa (DEB) is a heterogeneous and rare genetic skin disease caused by mutations in the COL7A1 gene, which encodes Type VII collagen. …”
    Get full text
    Article
  4. 964
  5. 965

    Consideration of the EXiLE test for predicting anaphylaxis after diclofenac etalhyaluronate administration by Haruyo Akiyama, Chisato Kurisaka, Dai Muramatsu, Shuhei Takada, Kei Toyama, Keiji Yoshioka, Ryosuke Nakamura

    Published 2024-12-01
    “…However, frequent cases of anaphylaxis induced by JCL administration have been reported. Recent clinical research suggests the potential utility of the basophil activation test (BAT) in predicting JCL-induced anaphylaxis. …”
    Get full text
    Article
  6. 966
  7. 967

    Barriers and facilitators to conducting human subjects research at a safety net institution from the perspective of researchers. by Sarah J Barnes, Yewon Na, Mari-Lynn Drainoni, Benjamin A Linas, Nicholas A Bosch, Autumn L Tamlyn

    Published 2025-01-01
    “…<h4>Introduction</h4>The COVID-19 pandemic revealed glaring problems with clinical research enterprise. Faced with crisis, several trials opened rapidly but enrolled homogenous populations with few Black, Indigenous, and People of Color (BIPOC) individuals. …”
    Get full text
    Article
  8. 968
  9. 969
  10. 970
  11. 971
  12. 972
  13. 973
  14. 974
  15. 975
  16. 976
  17. 977
  18. 978
  19. 979
  20. 980